The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomes

Area of Science:

• Cardiology
• Medical Technology
• Emergency Medicine

Background:

• Shortening door-to-balloon (D2B) time is critical for ST-segment elevation myocardial infarction (STEMI) treatment.
• The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) network enables early ECG transmission and triage.
• Previous reports indicated STAT-MI shortens D2B times; this study assesses its impact on infarct size, length of stay (LOS), and mortality.

Purpose of the Study:

• To evaluate the impact of the STAT-MI wireless network on patient outcomes in STEMI treatment.
• To assess the effect of STAT-MI on infarct size, hospital LOS, and mortality.
• To compare outcomes between STEMI patients managed via STAT-MI and those through conventional pathways.

Main Methods:

• A fully automated wireless network (STAT-MI) was implemented for 12-lead ECG transmission and direct cardiologist communication.
• Emergency medical services transmitted ECGs for early triage to the cardiac catheterization laboratory.
• Data from 92 STAT-MI patients were prospectively collected and compared with 50 concurrent control patients.

Main Results:

• STAT-MI patients experienced significantly shorter D2B times (63 min vs. 119 min).
• STAT-MI was associated with reduced peak troponin I and creatine phosphokinase-MB levels, indicating smaller infarct size.
• STAT-MI patients had higher left ventricular ejection fractions and shorter LOS (3 days vs. 5.5 days).

Conclusions:

• The STAT-MI wireless network effectively shortens D2B times in STEMI patients.
• Early evaluation and triage via STAT-MI reduce infarct size and limit ejection fraction reduction.
• The STAT-MI system leads to a significant decrease in hospital length of stay for STEMI patients.